hydrocodone bitartrate


Also found in: Dictionary.

hydrocodone bitartrate

(hī″drō-kō′dōn)
A very commonly prescribed opioid pain reliever.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
The company said the abbreviated new drug application (ANDA) for a Hydrocodone Bitartrate and Chlorpheniramine Maleate Oral Solution 5 mg/4 mg per 5 ml is bioequivalent product to VITUZ Oral Solution.
The dosage strengths and administration are 10, 15, 20, 30, 40 and 50 milligrams (mg) of hydrocodone bitartrate capsules and twice-daily (q12h) administration.
(Nasdaq:ZGNX), San Diego, a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, has announced that it has obtained the required long-term clinical exposure data from its Phase 3 open label safety study (Study 802) of Zohydro(TM) (hydrocodone bitartrate) extended-release capsules.
If additional pain medication was required after surgery, patients were allowed 1-2 opioid tablets (hydrocodone bitartrate 5 mg/acetaminophen 500 mg) every 4-6 hours, as needed.
- US-based specialty pharmaceuticals developer Acella Pharmaceuticals, LLC has received approval from the Food and Drug Administration's for its abbreviated new drug application for a hydrocodone bitartrate and chlorpheniramine maleate oral solution, 5 mg/4 mg per 5 mL, as a bioequivalent product to VITUZ Oral Solution, the company said.
M2 EQUITYBITES-June 27, 2017-Lannett wins US FDA approval for additional dosage strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP
has received final approval from the FDA for hydrocodone bitartrate and ibuprofen tablets, 7.5 mg/200 mg (C-II).
Joe Manchin (D-W.Va.) is urging the Department of Health & Human Services to overturn the Food and Drug Administration's approval of extended-release hydrocodone bitartrate (Zohydro ER), calling the drug "a powerful and dangerous opioid drug product with a high potential for abuse."
Food & Drug Administration (FDA) for QSC-001, a unique orally disintegrating tablet (ODT) formulation of hydrocodone bitartrate and acetaminophen (HB/APAP) for the treatment of moderate to moderately severe pain.
M2 PHARMA-June 27, 2017-Lannett wins US FDA approval for additional dosage strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP
M2 EQUITYBITES-June 23, 2017-Lannett wins US FDA approval for Hydrocodone Bitartrate and Acetaminophen Tablets USP in 5 mg/300 mg, 7.5 mg/300 mg and 10 mg/300 mg